Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

Rehm, 2009, Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders, Lancet, 373, 2223, 10.1016/S0140-6736(09)60746-7 Yoon Lieber, 1965, Effects of prolonged ethanol intake: production of fatty liver despite adequate diets, J Clin Invest, 44, 1009, 10.1172/JCI105200 Lieber, 1994, Susceptibility to alcohol-related liver injury, Alcohol Alcohol Suppl, 2, 315 Thurman, 1998, The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury, J Gastroenterol Hepatol, 13, S39, 10.1111/jgh.1998.13.s1.39 Tsukamoto, 2001, Current concepts in the pathogenesis of alcoholic liver injury, FASEB J, 15, 1335, 10.1096/fj.00-0650rev Hoek, 2002, Alcohol and mitochondria: a dysfunctional relationship, Gastroenterology, 122, 2049, 10.1053/gast.2002.33613 Lumeng, 2001, Alcoholic liver disease, Curr Opin Gastroenterol, 17, 211, 10.1097/00001574-200105000-00004 Arteel, 2003, Advances in alcoholic liver disease, Best Pract Res Clin Gastroenterol, 17, 625, 10.1016/S1521-6918(03)00053-2 Helman, 1971, Alcoholic hepatitis, Ann Intern Med, 74, 311, 10.7326/0003-4819-74-3-311 O'Shea, 2010, Alcoholic liver disease, Hepatology, 51, 307, 10.1002/hep.23258 Tsukamoto, 2009, “Second hit” models of alcoholic liver disease, Semin Liver Dis, 29, 178, 10.1055/s-0029-1214373 Wilfred de Alwis, 2007, Genetics of alcoholic liver disease and nonalcoholic fatty liver disease, Semin Liver Dis, 27, 44, 10.1055/s-2006-960170 Raynard, 2002, Risk factors of fibrosis in alcohol-induced liver disease, Hepatology, 35, 635, 10.1053/jhep.2002.31782 Naveau, 1997, Excess weight risk factor for alcoholic liver disease, Hepatology, 25, 108, 10.1002/hep.510250120 Xu, 2011, Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK, J Hepatol, 55, 673, 10.1016/j.jhep.2010.12.034 Hatton, 2009, Drinking patterns, dependency and life-time drinking history in alcohol-related liver disease, Addiction, 104, 587, 10.1111/j.1360-0443.2008.02493.x Tian, 2010, Variant in PNPLA3 is associated with alcoholic liver disease, Nat Genet, 42, 21, 10.1038/ng.488 Stickel, 2011, Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians, Hepatology, 53, 86, 10.1002/hep.24017 Trépo, 2011, Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease, J Hepatol, 55, 906, 10.1016/j.jhep.2011.01.028 Chen, 2010, Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease, Hepatology, 52, 1134, 10.1002/hep.23812 Gao, 2005, Alcohol and hepatitis virus interactions in liver pathology, 819 Siu, 2009, Hepatitis C virus and alcohol, Semin Liver Dis, 29, 188, 10.1055/s-0029-1214374 Baraona, 1979, Effects of ethanol on lipid metabolism, J Lipid Res, 20, 289, 10.1016/S0022-2275(20)40613-3 You, 2002, Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP), J Biol Chem, 277, 29342, 10.1074/jbc.M202411200 Esfandiari, 2010, Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse, Hepatology, 51, 932, 10.1002/hep.23382 Ji, 2004, Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury, Hepatology, 40, 442, 10.1002/hep.20309 Peng, 2009, Adenosine signaling contributes to ethanol-induced fatty liver in mice, J Clin Invest, 119, 582, 10.1172/JCI37409 Jeong, 2008, Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver, Cell Metab, 7, 227, 10.1016/j.cmet.2007.12.007 Zhao, 2008, TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol, J Immunol, 181, 3049, 10.4049/jimmunol.181.5.3049 Petrasek, 2011, Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells, Hepatology, 53, 649, 10.1002/hep.24059 McMullen, 2005, Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice, Gastroenterology, 128, 2066, 10.1053/j.gastro.2005.02.065 Yin, 1999, Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice, Gastroenterology, 117, 942, 10.1016/S0016-5085(99)70354-9 Hritz, 2008, The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88, Hepatology, 48, 1224, 10.1002/hep.22470 You, 2004, The role of AMP-activated protein kinase in the action of ethanol in the liver, Gastroenterology, 127, 1798, 10.1053/j.gastro.2004.09.049 You, 2008, Involvement of mammalian sirtuin 1 in the action of ethanol in the liver, Am J Physiol Gastrointest Liver Physiol, 294, G892, 10.1152/ajpgi.00575.2007 You, 2009, Adiponectin: a key adipokine in alcoholic fatty liver, Exp Biol Med (Maywood), 2009, 850, 10.3181/0902-MR-61 Horiguchi, 2008, Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury, Gastroenterology, 134, 1148, 10.1053/j.gastro.2008.01.016 Ji, 2006, Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model, J Hepatol, 45, 717, 10.1016/j.jhep.2006.05.009 Yu, 2003, Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis, Curr Mol Med, 3, 561, 10.2174/1566524033479537 Wagner, 2011, Nuclear receptors in liver disease, Hepatology, 53, 1023, 10.1002/hep.24148 Galli, 2001, The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism, J Biol Chem, 276, 68, 10.1074/jbc.M008791200 Lu, 2008, Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice, Hepatology, 47, 1483, 10.1002/hep.22222 You, 2005, Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice, Hepatology, 42, 568, 10.1002/hep.20821 Kang, 2009, Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha, Hepatology, 50, 1241, 10.1002/hep.23090 Viollet, 2009, AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives, Acta Physiol (Oxf), 196, 81, 10.1111/j.1748-1716.2009.01970.x Li, 2011, AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice, Cell Metab, 13, 376, 10.1016/j.cmet.2011.03.009 Nath, 2011, Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice, Hepatology, 53, 1526, 10.1002/hep.24256 Pritchard, 2007, Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice, Gastroenterology, 132, 1117, 10.1053/j.gastro.2007.01.053 Cohen, 2010, Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice, Gastroenterology, 139, 664, 10.1053/j.gastro.2010.04.041 Kaiser, 2009, PKCepsilon plays a causal role in acute ethanol-induced steatosis, Arch Biochem Biophys, 482, 104, 10.1016/j.abb.2008.11.004 McKim, 2003, Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice, Gastroenterology, 125, 1834, 10.1053/j.gastro.2003.08.030 Czaja, 2011, Functions of autophagy in hepatic and pancreatic physiology and disease, Gastroenterology, 140, 1895, 10.1053/j.gastro.2011.04.038 Donohue, 2009, Autophagy and ethanol-induced liver injury, World J Gastroenterol, 15, 1178, 10.3748/wjg.15.1178 Wu, 2010, CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophagy in HepG2 E47 cells, Biochem Biophys Res Commun, 402, 116, 10.1016/j.bbrc.2010.09.127 Ding, 2010, Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice, Gastroenterology, 139, 1740, 10.1053/j.gastro.2010.07.041 Lucey, 2009, Alcoholic hepatitis, N Engl J Med, 360, 2758, 10.1056/NEJMra0805786 Setshedi, 2010, Acetaldehyde adducts in alcoholic liver disease, Oxid Med Cell Longev, 3, 178, 10.4161/oxim.3.3.12288 Farfan Labonne, 2009, Acetaldehyde-induced mitochondrial dysfunction sensitizes hepatocytes to oxidative damage, Cell Biol Toxicol, 25, 599, 10.1007/s10565-008-9115-5 Kendrick, 2010, Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis, Hepatology, 51, 1988, 10.1002/hep.23572 Shen, 2009, Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines, Am J Physiol Gastrointest Liver Physiol, 296, G1047, 10.1152/ajpgi.00016.2009 Feldstein, 2005, Apoptosis in alcoholic and nonalcoholic steatohepatitis, Front Biosci, 10, 3093, 10.2741/1765 Tatsukawa, 2009, Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1, Gastroenterology, 136, 1783, 10.1053/j.gastro.2009.01.007 Yan, 2011, Enteric dysbiosis associated with a mouse model of alcoholic liver disease, Hepatology, 53, 96, 10.1002/hep.24018 Rao, 2009, Endotoxemia and gut barrier dysfunction in alcoholic liver disease, Hepatology, 50, 638, 10.1002/hep.23009 Roychowdhury, 2009, An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice, Hepatology, 49, 1326, 10.1002/hep.22776 Mandal, 2010, The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells, Hepatology, 51, 1420, 10.1002/hep.23427 Miller, 2011, Inflammation-associated IL-6/STAT3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in IL-10 deficient mice, Hepatology, 54, 846, 10.1002/hep.24517 Maltby, 1996, Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis, Hepatology, 24, 1156 Dominguez, 2009, Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis, Gastroenterology, 136, 1639, 10.1053/j.gastro.2009.01.056 Lemmers, 2009, The interleukin-17 pathway is involved in human alcoholic liver disease, Hepatology, 49, 646, 10.1002/hep.22680 Gomez-Quiroz, 2003, Interleukin 8 response and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde or lipopolysaccharide, Hepatol Res, 26, 134, 10.1016/S1386-6346(03)00010-X Joshi-Barve, 2007, Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes, Hepatology, 46, 823, 10.1002/hep.21752 Joshi-Barve, 2003, Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes, Hepatology, 38, 1178, 10.1053/jhep.2003.50470 Paik, 2006, Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid, Lab Invest, 86, 676, 10.1038/labinvest.3700422 Maher, 1995, Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol, Am J Physiol, 269, G518 Ramaiah, 2007, Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury, Toxicol Mech Methods, 17, 431, 10.1080/00952990701407702 Albano, 2010, Immune mechanisms in alcoholic liver disease, Genes Nutr, 5, 141, 10.1007/s12263-009-0151-4 Mottaran, 2002, Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease, Free Radic Biol Med, 32, 38, 10.1016/S0891-5849(01)00757-2 Thiele, 2010, Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites, Alcohol Clin Exp Res, 34, 2126, 10.1111/j.1530-0277.2010.01309.x Thiele, 2004, Immunologic mechanisms of alcoholic liver injury, Semin Liver Dis, 24, 273, 10.1055/s-2004-832940 Michalopoulos, 2007, Liver regeneration, J Cell Physiol, 213, 286, 10.1002/jcp.21172 Saso, 1997, Differential inhibition of epidermal growth factor signaling pathways in rat hepatocytes by long-term ethanol treatment, Gastroenterology, 112, 2073, 10.1053/gast.1997.v112.pm9178701 Bataller, 2005, Liver fibrosis, J Clin Invest, 115, 209, 10.1172/JCI24282 Friedman, 2008, Mechanisms of hepatic fibrogenesis, Gastroenterology, 134, 1655, 10.1053/j.gastro.2008.03.003 Purohit, 2006, Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium, Hepatology, 43, 872, 10.1002/hep.21107 Cubero, 2009, Alcohol and liver fibrosis, Semin Liver Dis, 29, 211, 10.1055/s-0029-1214376 Seki, 2007, TLR4 enhances TGF-beta signaling and hepatic fibrosis, Nat Med, 13, 1324, 10.1038/nm1663 Jagavelu, 2010, Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver, Hepatology, 52, 590, 10.1002/hep.23739 Inokuchi, 2011, Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice, Alcohol Clin Exp Res, 35, 1509 Mello, 2008, Alcohol induced hepatic fibrosis: role of acetaldehyde, Mol Aspects Med, 29, 17, 10.1016/j.mam.2007.10.001 Radaeva, 2006, Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners, Gastroenterology, 130, 435, 10.1053/j.gastro.2005.10.055 Muhanna, 2011, Amelioration of hepatic fibrosis by NK cell activation, Gut, 60, 90, 10.1136/gut.2010.211136 Jeong, 2006, STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity, Hepatology, 44, 1441, 10.1002/hep.21419 Jeong, 2008, Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis, Gastroenterology, 134, 248, 10.1053/j.gastro.2007.09.034 El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 Morgan, 2004, Alcohol and hepatocellular carcinoma, Gastroenterology, 127, S87, 10.1053/j.gastro.2004.09.020 McKillop, 2009, Role of alcohol in liver carcinogenesis, Semin Liver Dis, 29, 222, 10.1055/s-0029-1214377 Machida, 2009, Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog, Proc Natl Acad Sci U S A, 106, 1548, 10.1073/pnas.0807390106 Shukla, 2008, Emerging role of epigenetics in the actions of alcohol, Alcohol Clin Exp Res, 32, 1525, 10.1111/j.1530-0277.2008.00729.x Mato, 2008, Methionine metabolism and liver disease, Annu Rev Nutr, 28, 273, 10.1146/annurev.nutr.28.061807.155438 Visone, 2008, Micro-RNAs in gastrointestinal and liver disease, Gastroenterology, 135, 1866, 10.1053/j.gastro.2008.10.074 Bala, 2009, Emerging role of microRNAs in liver diseases, World J Gastroenterol, 15, 5633, 10.3748/wjg.15.5633 Miranda, 2010, MicroRNAs: master regulators of ethanol abuse and toxicity?, Alcohol Clin Exp Res, 34, 575, 10.1111/j.1530-0277.2009.01126.x Bala, 2011, Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease, J Biol Chem, 286, 1436, 10.1074/jbc.M110.145870 Tang, 2008, Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease, Alcohol Clin Exp Res, 32, 355, 10.1111/j.1530-0277.2007.00584.x Dolganiuc, 2009, MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice, Alcohol Clin Exp Res, 33, 1704, 10.1111/j.1530-0277.2009.01007.x Jung, 2008, Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans, Gastroenterology, 134, 1532, 10.1053/j.gastro.2008.02.022 Roskams, 2003, Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease, Am J Pathol, 163, 1301, 10.1016/S0002-9440(10)63489-X Dalakas, 2010, Bone marrow stem cells contribute to alcohol liver fibrosis in humans, Stem Cells Dev, 19, 1417, 10.1089/scd.2009.0387 Pai, 2008, Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis, Am J Gastroenterol, 103, 1952, 10.1111/j.1572-0241.2008.01993.x Spahr, 2008, Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial, Hepatology, 48, 221, 10.1002/hep.22317 Soyka, 2010, Emerging drugs to treat alcoholism, Expert Opin Emerg Drugs, 15, 695, 10.1517/14728214.2010.500811 Mohanty, 2004, Liver transplantation for disulfiram-induced fulminant hepatic failure, J Clin Gastroenterol, 38, 292, 10.1097/00004836-200403000-00018 Addolorato, 2010, Safety and efficacy of baclofen in the treatment of alcohol-dependent patients, Curr Pharm Des, 16, 2113, 10.2174/138161210791516440 Angulo, 2009, Noninvasive assessment of fibrosis and steatosis in NASH and ASH, Gastroenterol Clin Biol, 33, 940, 10.1016/j.gcb.2009.08.001 Martinez, 2011, Noninvasive assessment of liver fibrosis, Hepatology, 53, 325, 10.1002/hep.24013 Stickel, 2010, Alcoholic steatohepatitis, Best Pract Res Clin Gastroenterol, 24, 683, 10.1016/j.bpg.2010.07.003 Bergheim, 2005, Treatment of alcoholic liver disease, Dig Dis, 23, 275, 10.1159/000090175 Rongey, 2006, Current concepts and controversies in the treatment of alcoholic hepatitis, World J Gastroenterol, 12, 6909, 10.3748/wjg.v12.i43.6909 Imperiale, 1990, Do corticosteroids reduce mortality from alcoholic hepatitis?, Ann Intern Med, 113, 299, 10.7326/0003-4819-113-4-299 Mathurin, 2011, Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data, Gut, 60, 255, 10.1136/gut.2010.224097 Rambaldi, 2008, Systematic review: glucocorticosteroids for alcoholic hepatitis—a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials, Aliment Pharmacol Ther, 27, 1167, 10.1111/j.1365-2036.2008.03685.x Louvet, 2009, Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor, Gastroenterology, 137, 541, 10.1053/j.gastro.2009.04.062 Louvet, 2007, The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids, Hepatology, 45, 1348, 10.1002/hep.21607 Kendrick, 2010, Theophylline improves steroid sensitivity in acute alcoholic hepatitis, Hepatology, 52, 126, 10.1002/hep.23666 di Mambro, 2011, In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis, Hepatology, 53, 1316, 10.1002/hep.24159 Akriviadis, 2000, Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial, Gastroenterology, 119, 1637, 10.1053/gast.2000.20189 De, 2009, Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial, World J Gastroenterol, 15, 1613, 10.3748/wjg.15.1613 Whitfield, 2009, Pentoxifylline for alcoholic hepatitis, Cochrane Database Syst Rev, 10.1002/14651858.CD007339.pub2 Louvet, 2008, Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids, J Hepatol, 48, 465, 10.1016/j.jhep.2007.10.010 Spahr, 2002, Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study, J Hepatol, 37, 448, 10.1016/S0168-8278(02)00230-1 Naveau, 2004, A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis, Hepatology, 39, 1390, 10.1002/hep.20206 Boetticher, 2008, A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis, Gastroenterology, 135, 1953, 10.1053/j.gastro.2008.08.057 Cabre, 2000, Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial, Hepatology, 32, 36, 10.1053/jhep.2000.8627 Foody, 2001, Nutritional therapy for alcoholic hepatitis: new life for an old idea, Gastroenterology, 120, 1053, 10.1016/S0016-5085(01)83918-4 Stickel, 2003, Review article: nutritional therapy in alcoholic liver disease, Aliment Pharmacol Ther, 18, 357, 10.1046/j.1365-2036.2003.01660.x Lu, 2006, Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver disease, J Gastroenterol Hepatol, 21, S61, 10.1111/j.1440-1746.2006.04575.x Mato, 1999, S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial, J Hepatol, 30, 1081, 10.1016/S0168-8278(99)80263-3 Rambaldi, 2006, S-adenosyl-L-methionine for alcoholic liver diseases, Cochrane Database Syst Rev, 10.1002/14651858.CD002235.pub2 Burra, 2010, Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry), Am J Transplant, 10, 138, 10.1111/j.1600-6143.2009.02869.x Dureja, 2010, The place of liver transplantation in the treatment of severe alcoholic hepatitis, J Hepatol, 52, 759, 10.1016/j.jhep.2009.12.021 Rambaldi, 2002, Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review, Am J Gastroenterol, 97, 1674, 10.1016/S0002-9270(02)04182-5 Fede, 2011, Propylthiouracil for alcoholic liver disease, Cochrane Database Syst Rev, 6, 10.1002/14651858.CD002800.pub3 Mezey, 2004, A randomized placebo controlled trial of vitamin E for alcoholic hepatitis, J Hepatol, 40, 40, 10.1016/S0168-8278(03)00476-8 Pares, 1998, Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial, J Hepatol, 28, 615, 10.1016/S0168-8278(98)80285-7 Nguyen-Khac, 2009, Treatment of severe acute alcoholic hepatitis with corticoids plus N-acetyl cysteine versus corticoids alone: a multicentre, randomized, controlled trial, Hepatology, 50, 346A Bird, 1990, Increased plasma tumor necrosis factor in severe alcoholic hepatitis, Ann Intern Med, 112, 917, 10.7326/0003-4819-112-12-917 Colmenero, 2007, Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity, Gastroenterology, 132, 687, 10.1053/j.gastro.2006.12.036 Ki, 2010, Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3, Hepatology, 52, 1291, 10.1002/hep.23837 Charbel Issa, 2011, The significance of the complement system for the pathogenesis of age-related macular degeneration — current evidence and translation into clinical application, Graefes Arch Clin Exp Ophthalmol, 249, 163, 10.1007/s00417-010-1568-6 Mencin, 2009, Toll-like receptors as targets in chronic liver diseases, Gut, 58, 704, 10.1136/gut.2008.156307 Bass, 2010, Rifaximin treatment in hepatic encephalopathy, N Engl J Med, 362, 1071, 10.1056/NEJMoa0907893 Pockros, 2007, Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C, Hepatology, 46, 324, 10.1002/hep.21664 Shiffman, 2010, Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor — a randomized placebo-controlled study in patients with chronic hepatitis C, Aliment Pharmacol Ther, 31, 969 Ratziu, 2010, Safety, tolerability and preliminary activity of GS-9450, a selective caspase inhibitor, in patients with non-alcoholic steatohepatitis, J Hepatol, 52, S38, 10.1016/S0168-8278(10)60086-4 Seth, 2006, Intrahepatic gene expression in human alcoholic hepatitis, J Hepatol, 45, 306, 10.1016/j.jhep.2006.04.013 Tam, 2011, Endocannabinoids in liver disease, Hepatology, 53, 346, 10.1002/hep.24077 Louvet, 2011, Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice, Hepatology, 54, 1217, 10.1002/hep.24524 Mookerjee, 2007, Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis, Gastroenterology, 132, 2533, 10.1053/j.gastro.2006.12.035